DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Hatemi G, Melikoglu M, Tunc R. et al.
Apremilast for Behcet’s syndrome – a phase 2, placebo-controlled study.
N Engl J Med 2015;
372: 1510-1518
We do not assume any responsibility for the contents of the web pages of other providers.